After the study of induced pluripotent stem cells (iPS), which enabled dedifferentiation by regulating four genes [88, 89], an extended study revealed that two regulators, BCL11A and HDAC1/2, have been identified in the gene regulatory network for reprogramming cancer cells [88, 89]. The gene discussed is BCL11A; the disease is cancer.